Lipase.

Bile salts emulsify dietary fat into droplets and, with colipase, anchor lipase at the lipid and water interface where it can work. Without adequate bile salts a lipase dose has little surface to act on.

Pancreatic-type lipase works near neutral pH and loses activity as duodenal contents stay acidic. Bicarbonate raises the pH into the enzyme's working range.

Betaine HCl lowers gastric pH, which suits pepsin but inactivates uncoated pancreatic-type lipase before it reaches the small intestine. Enteric protection or separate timing keeps the lipase activity intact.

Lipase covers triglycerides while amylase covers starch, so the two handle separate substrates in the same meal. Digestive blends carry both because neither substitutes for the other.

Bromelain supplies protease activity across a wide pH range while lipase handles the lipid fraction. The pairing widens substrate coverage in a mixed meal.

Lactase splits lactose at the brush border while lipase handles the milk fat in the same dairy meal. They cover two different components of one food.

Triglyceride-form omega-3 has to be cleaved by lipase into free fatty acids and monoglycerides before micellar uptake. Adequate lipase activity raises the absorbed EPA and DHA share from the same dose.

CoQ10 is a large lipophilic molecule that depends on fat digestion and micelle formation to cross the enterocyte. Lipolysis of the carrier oil is the rate-limiting step for its uptake.

Fat-soluble vitamins enter mixed micelles only after dietary triglyceride has been broken down by lipase. Low lipolytic activity lowers the absorbed fraction of a vitamin D dose.

Tocopherol esters need both lipolysis and micelle formation before uptake, and lipase supplies the first step. The same applies to the other fat-soluble vitamins in the meal.

Medium-chain triglycerides are hydrolysed quickly and their fatty acids move into portal blood with much less dependence on bile and micelles. They deliver usable fat energy through a route that runs alongside conventional long-chain lipolysis.

Activated charcoal adsorbs proteins and lipids indiscriminately in the gut lumen, including a dosed enzyme and the fat it was meant to act on. The two belong hours apart.

Pancreatin already contains lipase, amylase and protease, so adding a separate lipase raises total lipolytic activity rather than adding a new function. Anyone combining the two should count total lipase units once across both products. Enzyme labels state activity in FIP or USP units, which is what to compare rather than milligrams.

Broad digestive enzyme blends normally already declare a lipase activity alongside protease, amylase and sometimes cellulase and lactase. Stacking a standalone lipase on top increases the lipolytic share of the blend. The consideration is duplicated activity, not an interaction.

Pepsin needs an acid pH to cleave peptide bonds in the stomach, while classical pancreatic lipase works at near-neutral duodenal pH and acid-stable fungal lipases can work earlier. Because they act on different substrates in different compartments, they complement rather than compete. Textbook sequence, no trial needed.

Papain is a cysteine protease from papaya that hydrolyses peptide bonds, leaving lipid esters untouched. Combining it with lipase covers protein and fat with separate catalysts. No substrate competition exists between them.

Phytase hydrolyses the phosphate groups off inositol hexaphosphate, a reaction with no overlap with triglyceride hydrolysis. Both enzymes appear together in blends aimed at getting more out of a mixed meal. They act on separate substrates and do not compete.

Fat-soluble vitamins are released from a food or capsule matrix as the surrounding triglyceride is hydrolysed and taken into mixed micelles. Lipolysis is therefore a physical prerequisite for retinoid uptake. This is an absorption step; it says nothing about vitamin A status as an outcome.

MK-7 is delivered in an oil or a fatty matrix, and it enters mixed micelles as that matrix is hydrolysed. Lipolytic capacity is one determinant of how much becomes available. The interaction sits at absorption only.

Beta-carotene must transfer from the food matrix into the lipid droplet and then into mixed micelles, a transfer driven by lipolysis at the droplet surface. Measured bioaccessibility rises with lipolytic activity in digestion models. Bioaccessibility is a laboratory marker rather than a clinical outcome.

Lutein partitions into the emulsified lipid phase and then into micelles as that phase is digested. Without lipolysis it stays in the oil droplet. This is the same absorption-step relationship as for the other carotenoids.

Zeaxanthin follows lutein through the same lipid-dependent route from droplet to micelle to enterocyte. Lipolytic activity is therefore one of its absorption determinants. No outcome claim is attached.

Lycopene is among the least water-soluble dietary carotenoids and its release depends on both the amount of fat present and how completely that fat is hydrolysed. Lipase activity is one half of that equation. Plasma lycopene is a marker of absorption.

Astaxanthin from algal sources is partly esterified, so both ester hydrolysis and micellar incorporation depend on lipolytic activity in the lumen. Formulators deliver it in oil for that reason. The relationship is at absorption.

A large share of krill oil fatty acids sit on phospholipids rather than triglycerides, so their release involves phospholipase A2 alongside triglyceride lipase for the remaining neutral lipid fraction. Lipolytic capacity therefore still bears on how the oil is handled. Which enzyme dominates depends on the lipid class in the specific oil.

Curcuminoids are poorly water-soluble and are commonly delivered in an oil, a phospholipid complex or an emulsion, all of which are digested before the payload becomes available. Lipolysis of that carrier is one step in the sequence. This concerns absorption of a formulation, not an effect of curcumin.

Free fatty acids liberated by lipase can precipitate with calcium as insoluble soaps in the intestinal lumen, which removes them from micellar uptake and increases faecal fat. That is settled chemistry and it is why a large calcium dose and a fat-heavy meal interact. Taking the two apart is the straightforward handling.

Psyllium forms a viscous gel that reduces the rate at which lipid droplets are emulsified and at which digestion products diffuse to the mucosa. In practice this lowers measured fat digestion rather than the total, and it works against what a lipase dose is added for. Separating a fibre dose from a fat-heavy meal is the usual accommodation.

Guar gum increases luminal viscosity, which restricts the enzyme access and diffusion that lipolysis depends on. Digestion models consistently show slower lipid hydrolysis in its presence. That is a rate effect, not proof that nothing is absorbed.

Glucomannan is among the more viscous soluble fibres and it slows gastric emptying and lipid digestion in the same way as other gel formers. Anyone taking it for satiety and also taking lipase for fat handling is pushing in two directions in one meal. Dose timing resolves most of it.

Bile salt hydrolase activity in certain strains deconjugates bile acids, and deconjugated bile salts emulsify lipid differently from conjugated ones. Some strains also contribute their own lipolytic and esterase activity. Direction and size of the net effect on a supplemental lipase dose are unquantified in people, so this is a modulating flag rather than a benefit claim.

This yeast is commonly co-taken with digestive enzyme blends and contributes its own hydrolytic activity to the lumen. Whether that changes what a supplemental lipase achieves has not been measured. The pairing is common practice rather than a demonstrated interaction.

Phytosterols displace cholesterol and compete for micellar capacity, which is the accepted mechanism behind their effect on cholesterol absorption. Because micelle capacity is shared, a large sterol dose changes the environment into which lipase products are released. This is competition for a shared carrier, not enzyme inhibition.

Tocotrienols are supplied in an oil base and reach micelles as that base is hydrolysed. Lipolytic activity is one determinant of how much is released. The interaction is at absorption only.